Contraceptive Counselling: Impact on Awareness of the Risk of Unwanted Pregnancy and on the Appeal of Contraception (CMC)

Le Conseil Minimal Autour de la Contraception : Quel Impact Sur la Prise de Conscience du Risque de Grossesse Non désirée et Sur l'Attrait à la Contraception

The hypothesis of this study is that the generalisation of minimal contraceptive advice in general medical consultations among women of childbearing age in Reunion Island who do not use contraception but who have sexual relations and do not wish to become pregnant within the year could induce an awareness of the risk of unwanted pregnancy and lead to a change in behaviour with regard to contraceptive methods.

Study Overview

Status

Active, not recruiting

Conditions

Study Type

Observational

Enrollment (Actual)

117

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint-Philippe, Réunion, 97442
        • Cabinet de médecine générale

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

On the basis of 30 participating GPs, the estimation of the number of inclusions is 400 women, which seems sufficient for this study.

The desired number of inclusions is 45 women/month (400 women over 9 months).

Description

Inclusion Criteria:

  • Women from 18 to 50 years old
  • Consulting in a general practice in Reunion Island
  • French or Creole speaking
  • Not having any contraceptive means
  • Having sexual intercourse
  • Not having any desire to become pregnant within the year
  • Collection of non-opposition

Exclusion Criteria:

  • Consultation for a desire or follow-up of a pregnancy
  • Consultation for an abortion
  • Consultation for a contraceptive method
  • Known infertility
  • Inability to answer the telephone (hearing impaired, mute)
  • Severe cognitive disorder (mental retardation, dementia, active psychosis)
  • Women under guardianship or curatorship

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Impact of a minimal councelling regarding the contraception awareness of risk of unwanted pregnancy
Time Frame: between Day 1 and Month 1
Change of Proportion of women with no contraception and having sexual relations without a desire of pregnancy
between Day 1 and Month 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sébastien LERUSTE, MD, Universite de La Reunion

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 15, 2022

Primary Completion (Actual)

December 15, 2022

Study Completion (Anticipated)

January 15, 2023

Study Registration Dates

First Submitted

July 21, 2022

First Submitted That Met QC Criteria

January 6, 2023

First Posted (Estimate)

January 9, 2023

Study Record Updates

Last Update Posted (Estimate)

January 9, 2023

Last Update Submitted That Met QC Criteria

January 6, 2023

Last Verified

July 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2021/CHU/34

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Contraception

Subscribe